Magazine

The leading source for ASAM society and addiction medicine news.

ASAM Releases White Paper on Drug Testing

by Beth Haynes | Dec 16, 2013

On December 12, 2013, ASAM released a white paper that reviews the science and current practice of drug testing. Though not a clinical guideline, the white paper does explore the wide range of applications for drug testing and its utility in a variety of medical and non-medical settings.

ASAM's white paper promotes the use of drug testing as a primary prevention, diagnostic, and monitoring tool in the management of addiction or drug misuse in medical practice.

To view the entire press release, click here.

To read the white paper, click here.

Features

PCSS Graphic

Ask the PCSS Expert: Counseling Requirements in Addiction Treatment?

A physician wrote the PCSS mentor network seeking advice on what type of counseling (group/individual/ AA, NA/ therapist) are typically required as part of addiction treatment.

neurons

Brain Stimulation as a Potential Treatment for Addiction

Brain stimulation has been in use for decades as a potential treatment for psychiatric disorders. However, its use in addiction is relatively new.

Unite ImageJoin Rally and Advocate for Addiction Solutions

Help tell our nation’s leaders that we support public health solutions to addiction.

image of the ASAM sealASAM Speaks on FDA Boxed Warnings

ASAM testified on the best approaches to communicating information about the fetal effects in product labeling for methadone and buprenorphine

Photo of Alex Krawczyk-KeefeThe Importance of Donating: One Family’s Story

A donation to honor a son and help those facing the devastating disease of addiction.

Education & Training

ASAM Releases White Paper on Drug Testing

by Beth Haynes | Dec 16, 2013

On December 12, 2013, ASAM released a white paper that reviews the science and current practice of drug testing. Though not a clinical guideline, the white paper does explore the wide range of applications for drug testing and its utility in a variety of medical and non-medical settings.

ASAM's white paper promotes the use of drug testing as a primary prevention, diagnostic, and monitoring tool in the management of addiction or drug misuse in medical practice.

To view the entire press release, click here.

To read the white paper, click here.

Government Affairs

ASAM Releases White Paper on Drug Testing

by Beth Haynes | Dec 16, 2013

On December 12, 2013, ASAM released a white paper that reviews the science and current practice of drug testing. Though not a clinical guideline, the white paper does explore the wide range of applications for drug testing and its utility in a variety of medical and non-medical settings.

ASAM's white paper promotes the use of drug testing as a primary prevention, diagnostic, and monitoring tool in the management of addiction or drug misuse in medical practice.

To view the entire press release, click here.

To read the white paper, click here.

Your ASAM

ASAM Releases White Paper on Drug Testing

by Beth Haynes | Dec 16, 2013

On December 12, 2013, ASAM released a white paper that reviews the science and current practice of drug testing. Though not a clinical guideline, the white paper does explore the wide range of applications for drug testing and its utility in a variety of medical and non-medical settings.

ASAM's white paper promotes the use of drug testing as a primary prevention, diagnostic, and monitoring tool in the management of addiction or drug misuse in medical practice.

To view the entire press release, click here.

To read the white paper, click here.

OP-ED

ASAM Releases White Paper on Drug Testing

by Beth Haynes | Dec 16, 2013

On December 12, 2013, ASAM released a white paper that reviews the science and current practice of drug testing. Though not a clinical guideline, the white paper does explore the wide range of applications for drug testing and its utility in a variety of medical and non-medical settings.

ASAM's white paper promotes the use of drug testing as a primary prevention, diagnostic, and monitoring tool in the management of addiction or drug misuse in medical practice.

To view the entire press release, click here.

To read the white paper, click here.